Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-006029-29Phase 4Completed
Phase 4 trial of Cirkalm (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change in average anal pain over the first 14 days. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-006029-29.